Strategies for Employers to Help Employees Who Want to Quit Using Tobacco
Using your company’s health plan to help employees and their families quit using tobacco
Research shows that the most effective tobacco dependence treatment includes medication(s) and
coaching/counseling - this combination can double or triple the employee’s chances of quitting
successfully. Businesses that have included a tobacco dependence treatment benefit in their health plan
report that this coverage has reduced total tobacco consumption, increased the number of tobacco-users
willing to undergo treatment, increased productivity and increased the percentage of those who
successfully quit
Below are common tobacco dependence treatment benefits and guidelines. Compare what you now
spend on tobacco-related illnesses and lost productivity with the cost of providing effective tobacco
cessation services for employees.

Are tobacco dependence treatment health benefits cost-effective?

 Tobacco cessation is more cost-effective than most other common and covered disease prevention interventions, such as treatment of hypertension and high cholesterol.  It costs between 10 and 40 cents per member per month to provide a comprehensive tobacco dependence treatment benefit (costs vary based on utilization and dependent coverage).  Employees who smoke have a high average insured payment for health care – $1,145 vs. $762
Questions to ask when purchasing health insurance for your employees

 How does the health plan identify/document tobacco-users and tobacco cessation interventions?  Covered tobacco dependence treatment drugs. How frequently offered, and for what period annually? Multiple medications covered? Multiple quit attempts covered in one 12 month period?  What type of counseling (e.g., in person, online, telephone) is covered? How often is counseling covered annually and for what period (e.g., 90 days twice per year)?  Is co-pay in line with other medications in the plan?  Are over-the-counter medications (nicotine patch, gum, lozenge) covered? Is there a co-pay?  Who is eligible for tobacco cessation benefits/drugs/counseling? Does this include all covered individuals or only those with a drug benefit?  What other educational or counseling materials are provided (e.g., hard copy, on-line, other)?  How does the plan motivate healthcare providers to provide tobacco cessation (bonuses)?  Are tobacco dependence treatment benefits promoted to the employees? How?  How is the percentage of tobacco-users who have received treatment assessed? How is the success of the tobacco cessation initiatives evaluated?
Health benefit design
Effective tobacco dependence treatment benefits address the following:
 Pay for counseling and medications.  Offer the FDA-approved medications, including prescription and over-the-counter.  Cover counseling services, including telephone and individual counseling. Show your employees you want to help them quit tobacco by designing a benefit that makes it easier for them.  Eliminate co-payments or require employees to pay no more than the standard co-payment. Tobacco-users rarely use cessation services inappropriately, and are much more likely to attempt to quit when no co-payment is required. Utilization averages 3 to 8% of tobacco users per year.  Provide at least two courses of treatment – both medication and counseling – per year. Tobacco dependence is a chronic disease. Relapse is part of the process. Tobacco dependence treatment medications
 Chantix (varenicline)  Zyban/Wellbutrin (bupropion SR 150)  Nicotine inhaler  Nicotine nasal spray Over the counter:
 Nicotine gum  Nicotine lozenge  Nicotine patch (can also be prescription)
Support for employees who use tobacco

The effect of implementing a tobacco-free policy will be most immediate for employees who use tobacco.
Tobacco cessation assistance and support will help employees adjust to behavioral and physical
changes. Although 70% of smokers indicate they would like to quit smoking, not all smokers will make a
serious attempt to quit at the same time and not all tobacco-users will respond to the same program for
quitting. Because of this diversity there should be options available for employees. In order to build
support it is also important to educate your non-tobacco-using employees.

Tobacco dependence treatment options

The most successful and highest recommended treatment option is physician/health care provider
support and monitoring along with medication and counseling.
1. Healthcare Provider Counseling: Healthcare providers play a critical role in tobacco treatment by
counseling patients about tobacco addiction, monitoring their progress, providing information about
medications and following up to reduce relapse.
2. Medications: Nicotine replacement therapies, as well as bupropion SR and varenicline help the
tobacco user fight the physical addiction. Most products are available by prescription; the nicotine patch,
gum and lozenge are available over-the-counter.
3. Wisconsin Tobacco Quit Line; 800-QUIT-NOW: The Quit Line provides information on quitting
tobacco use, one-on-one, practical counseling on how to increase the chance for success and referrals
to local quit smoking programs and services. All services are free and confidential.
4. Wisconsin Community Resource Guide for local services (by county):

Support for employers wanting assistance
The American Lung Association in Wisconsin also offers resources for employers to assist smokers who
wish to quit. These include group and on-line versions of our premiere smoking cessation program,
Freedom From Smoking®; a customized cessation program for teens called Not On Tobacco (N-O-T),
and our free Lung HelpLine, offering telephone counseling by registered nurses and respiratory
For information on all of the Lung Association cessation programs and services, visitor
call 1-800-LUNG-USA (586-4872).
February 2010

Source: https://www.wellnesscouncilwi.org/userfiles/file/Employers_quitplan.pdf

Microsoft word - 2008_02_mangieri_english_formatiert.doc

Animal research highlights a therapeutic potential of cannabinoids for the treatment of depression Regina A. Mangieri Department of Pharmacology, The University of Texas at Austin, Austin, TX 78712, USA Abstract Long known for their mood altering effects, cannabinoids are currently under investigation for their therapeutic potential in the treatment of depression. Findings from multi


A Paranoid’s Guide to HistoryINRECO doc #2Section 818.08pgPsychology DivisionSchizophrenia and its Neurological ConnectionsSchizophrenia is a multi-symptom, neural-psychologicaldisease with an elusive pathology. There have beenincreasing discussions as to the accuracy and functionalityof the term schizophrenia applied to such a wide rangesymptoms (Andreasen, 1999; Walters). One reason for

Copyright © 2010 Find Medical Article